Skip to content
Schedule a demo
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Centrum für Integrierte Onkologie

InstitutionResearch output, impact & collaborations

Centrum für Integrierte Onkologie is a institution indexed in PICO Portal from OpenAlex.

What is known about Centrum für Integrierte Onkologie?

PICO Portalrecord summary

Centrum für Integrierte Onkologie is a research organisation in Bonn, DE. OpenAlex records 7,079 works and 118,449 citations for it. 1,780 researchers list it as their most recent affiliation.

How many works does Centrum für Integrierte Onkologie have?

PICO Portalindexed works

Centrum für Integrierte Onkologie has 7,079 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Centrum für Integrierte Onkologie have?

PICO Portalcitation count

Centrum für Integrierte Onkologie has 118,449 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Centrum für Integrierte Onkologie?

PICO Portalresearcher count

Centrum für Integrierte Onkologie has 1,780 researchers in the PICO Portal index.

What is the average h-index at Centrum für Integrierte Onkologie?

PICO Portalavg h-index

Centrum für Integrierte Onkologie has an average h-index of 68 in OpenAlex.

What is the ROR of Centrum für Integrierte Onkologie?

PICO Portalror

The ROR for Centrum für Integrierte Onkologie is on the source record.

What is the OpenAlex record for Centrum für Integrierte Onkologie?

PICO Portalopenalex

The OpenAlex for Centrum für Integrierte Onkologie is on the source record.

Who are the most-cited researchers behind Centrum für Integrierte Onkologie?

PICO Portaltop researchers by citations
1
Rita K. Schmutzler · BRCA gene mutations in cancer
291 works29,155 citations

What are the most-cited papers on Centrum für Integrierte Onkologie?

PICO Portalmost cited works
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh, James Carmichael, Richard T. Penson, Michael Friedländer, Bethan Powell, Katherine M. Bell‐McGuinn, Clare L. Scott, Jeffrey N. Weitzel, Ana Oaknin, Niklas Loman, Karen H. Lu, Rita K. Schmutzler, Ursula A. Matulonis, Mark Wickens, Andrew Tutt
The Lancet. 20102,292 Citations
Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer
Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer
New England Journal of Medicine. 20211,704 CitationsOPEN ACCESS

How much of the research on Centrum für Integrierte Onkologie is open access?

PICO Portalopen access share
50%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
50%
Closed
50%

Related on PICO Portal

Biomedical and Chemical Research
Top Topic
Medical and Health Sciences Research
Top Topic
Health and Medical Studies
Top Topic
Palliative Care and End-of-Life Issues
Top Topic
Lymphoma Diagnosis and Treatment
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
470M+ articles · 14-day free trial